ArticleForensic science, medicine, and pathology2026
Histological artifacts induced by the contrast agent in multi-phase post-mortem CT angiography (MPMCTA): Part II - Pathological tissues.
Article in Forensic science, medicine, and pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multi-phase postmortem computed tomography angiography (MPMCTA) is increasingly used in forensic pathology; however, contrast medium injection may induce histo-morphological artifacts. While these artifacts have been previously described in normal tissues, their behavior in pathological conditions remains incompletely characterized. A retrospective study was conducted on 37 cases of sudden death undergoing MPMCTA. A total of 190 histological samples showing pathological alterations, previously excluded from the analysis of normal tissues, were examined. Tissue sections were processed using standard histological techniques and analyzed by experienced forensic pathologists to identify and characterize contrast-related artifacts in the presence of underlying disease. The main categories of artifacts-optically empty spaces (OES), vascular dilatation, hyperemia, and compression of adjacent structures-were consistently observed in pathological tissues. However, their distribution and morphology were frequently modified by the underlying disease. Inflammatory, neoplastic, hemorrhagic, and degenerative conditions were associated with heterogeneous contrast distribution and uneven perfusion patterns. OES were observed both within vascular lumina and in extravascular compartments, particularly in hemorrhagic and necrotic areas. Despite these alterations, the recognition of the underlying pathological processes was generally preserved. Relevant diagnostic pitfalls were identified, particularly in the differential diagnosis with fat embolism, gas-related changes, and cholesterol clefts. MPMCTA induces reproducible histo-morphological artifacts also in pathological tissues, although their distribution and appearance are influenced by the underlying disease. Awareness of these changes is essential to avoid misinterpretation. When properly recognized, contrast-related artifacts do not preclude accurate histopathological diagnosis and support the integrated use of imaging, autopsy, and histology in forensic practice.
Indexed as
Identifiers
42201606What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.